# Intermittent Preventive Treatment (IPTc) and Home Based Management of Malaria (HMM)in The Gambia

> **NCT00944840** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 1312 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** SP plus amodiaquine
- **DRUG:** SP placebo plus amodiaquine placebo

## Key facts

- **NCT ID:** NCT00944840
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 1312 (ACTUAL)
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944840, "Intermittent Preventive Treatment (IPTc) and Home Based Management of Malaria (HMM)in The Gambia". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT00944840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*